[ Main Page | Editorial Board | About | Instructions ]
[ Table of Contents | Archive | Archive Search | Online Submission | Sponsor | E-mail ]

Turkish Journal of Cancer
2008, Volume 38, Number 4, Page(s) 184-189
[ Summary ] [ Full Text ] [ PDF ]
The regulation of p21Waf1/Cip1, p27Kip1 and p57Kip2 gene expression in response to hydrocortisone, progesterone and ß-estradiol in HL-60 myeloid leukemia cells
ESİN MERVE EROL1,2, MİLAS UĞUR1,3, SAMET ÖKSÜZ1,3, TUNÇ FAİK ERSOY1,4, GÜNEŞ ESENDAĞLI5, DİCLE GÜÇ5
1Hacettepe University, Institute of Oncology, Department of Basic Oncology, Summer Training Program 2007, Ankara-Turkey
2Hacettepe University, Medical Faculty , 4th term student, Ankara-Turkey
3Middle East Technical University, Faculty of Science, Department of Molecular Biology, 3rd term student, Ankara-Turkey
4St. John’s University, College of Liberal Arts and Sciences, Department of Biological Sciences, 1st term student, NY-USA
5Hacettepe University, Institute of Oncology, Department of Basic Oncology, Ankara-Turkey

Steroid agents have crucial regulatory effects on cell differentiation and proliferation of different cell types. In this study, the influence of progesterone, ß-estradiol and hydrocortisone on the expression of cyclin dependent kinase inhibitor (CDKI) genes, p21Waf1/Cip1, p27Kip1 and p57Kip2 was assessed in HL-60 myeloid leukemia cells. Although treatment with these steroid agents did not significantly change the morphology of HL-60 cells, expression levels of p21 and p27 genes were modulated. p57 gene was not expressed in HL-60 cells. The overall data implied that G1/S transition in myeloid leukemia cells may be primarily regulated through p21Waf1/Cip1 and with a lesser extent through p27Kip1 expression upon incubation with steroids. [Turk J Cancer 2008;38(4):184-189]

[ Summary ] [ Full Text ] [ PDF ]
Turkish Journal of Cancer web sitesi Novartis Onkoloji'nin karşılıksız eğitim katkılarıyla hazırlanmıştır.
[ Main Page | Editorial Board | About | Instructions ]
[ Table of Contents | Archive | Archive Search | Online Submission | E-mail ]